In our original research article, there was an error in the *Materials and Methods* section, subsection *3D Microfluidic Co-Culture and Blocking Experiments*, where it was written that 100 µg/mL of anti-PD-L1-blocking or anti-PD-1-blocking antibody or their respective isotype control was used. The correct concentration is 10 µg/mL. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.
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